CareDx reports incentive grants pursuant to Nasdaq Listing Rule 5635(c)(4)

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company – a leading precision medicine company focused on discovering, developing and commercializing clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that 14 new employees have received restricted stock units (RSUs) for an aggregate of 44,000 shares of common stock as an incentive to begin employment with CareDx on September 12, 2024. The RSUs were granted pursuant to the Company’s 2019 Inducement Equity Incentive Plan, which was approved by the Compensation Committee of the Board of Directors in August 2019 under Nasdaq Listing Rule 5635(c)(4).

RSUs equal to 9,000 shares vest over four years, with 25% of the RSUs vesting on the first anniversary of the applicable vesting date and the remainder vesting annually in three equal installments thereafter, subject to the grantee’s continued employment through each applicable vesting date. RSUs equal to 14,000 shares vest over four years, with 25% of the RSUs vesting on the first anniversary of the applicable vesting date and the remainder vesting quarterly for three years thereafter, subject to the grantee’s continued employment through each applicable vesting date. RSUs for 18,000 shares vest over three years, with 33.33% of the RSUs vesting on the first anniversary of the applicable vesting date and the remainder vesting quarterly over two years thereafter, subject to the grantee’s continued employment through each applicable vesting date. RSUs for 2,000 shares vest over two years, with 50% of the RSUs vesting on each of the first two anniversaries of the applicable vesting date, subject to the grantee’s continued employment through each applicable vesting date. RSUs for 1,000 shares vest over two years, with 50% of the RSUs vesting on the first anniversary of the applicable vesting date and the remainder vesting quarterly over the following year, subject to the grantee’s continued employment through each applicable vesting date.